symmetric dimethylarginine has been researched along with Extramembranous Glomerulopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coyne, MJ; Cross, J; Drake, C; Mack, R; McCrann, DJ; Murphy, RE; Schultze, AE; Strong-Townsend, M | 1 |
1 other study(ies) available for symmetric dimethylarginine and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
Evaluation of renal injury and function biomarkers, including symmetric dimethylarginine (SDMA), in the rat passive Heymann nephritis (PHN) model.
Topics: Animals; Arginine; Biomarkers; Creatinine; Cystatin C; Dogs; Glomerulonephritis, Membranous; Kidney; Lipocalin-2; Nitrogen; Rats; Sheep | 2022 |